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Abstract
Purpose – Substance abuse has become a major health issue in Thailand, contributing to high numbers of
premature deaths and requiring considerable expenditure on treatment and rehabilitation programs. The
purpose of this paper is to explore use of Vipassana meditation to reduce depression and improve empathy
and self-awareness in drug dependent women at a rehabilitation centre.
Design/methodology/approach – Mixed methods were employed. Data were collected in a randomised
controlled trial and focus group interviews with 24 intervention subjects and 22 controls.
Findings – Findings showed no significant differences in depression, empathy or mindfulness levels
between intervention and control groups, but intervention subjects had a small decline in depression at
one-month follow up. The focus group interviews showed that drug users had developed self-awareness,
moral values and greater understanding of right and wrong acts.
Originality/value – Findings suggest that Vipassana meditation which is cultural appropriate for
Thai culture and religion, should be incorporated into treatments in rehabilitation centres to increase
successful outcomes.
Keywords Qualitative research, Quantitative research, Inpatient, Substance dependence, Drugs, Trial
Paper type Research paper
Introduction
Substance abuse is a costly burden for the Thai government’s health budget, with an estimated
220,000 drug users needing treatment and rehabilitation programs in 2016 (Health Focus,
2016). There are several public drug rehabilitation centres in each region, but these are struggling
to keep up with the needs of the growing number of drug users (Fairbairn et al., 2015). While
multiple approaches are available for substance use disorders, traditional treatments often result
in high relapse rates and improvements are required (Maisto et al., 2003; Witkiewitz and Masyn,
2008). The Therapeutic Community (TC) has been well recognised for promoting behavioural
changes for persons with substance abuse disorders (SUDs) (De Leon, 2000). A TC model is
based on peer confrontation to create a therapeutic atmosphere for behavioural change and
identify issues around drug addictions. A confrontation approach may be inappropriate in some
situations with hierarchal power structures and especially for women with SUDs, because
confrontation from peers might exacerbate feelings of oppression that lead to low self-esteem
and reduce the chances of successful recovery (Eliason, 2006). Although the efficacy and
effectiveness of TCs for treating drug users has been demonstrated, they cannot be considered
suitable for all cases, given the great diversity of drug users and illegal drugs. Clinicians have
sought culturally appropriate contemporary approaches, and mindfulness-based interventions
have gained attention (Zgierska et al., 2009). Mindfulness training has been considered a
promising treatment for substance abuse (Chiesa and Serretti, 2014; Katz and Toner, 2013)
through enhancing cognitive awareness for better monitoring of automatic cognitive and
emotional processes which are similar to the TC effectiveness. Fundamental behavioural
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changes and enhanced self-awareness are seen in mindfulness meditation and TC programmes
(Lange, 2011). Results have shown reductions in craving, substance seeking and using, and
improvement in psychological disorders (Garland et al., 2014; Witkiewitz et al., 2014). Multiple
mindfulness-based interventions have been evaluated as effective against substance use,
including Vipassana meditation (VM) (Bowen et al., 2006) and mindfulness-based stress
reduction (Davis et al., 2007).
Vipassana is derived from an ancient Buddhist tradition that originated in India and spread
throughout the world, particularly in southeast Asia including Thailand (Hart, 1987). Vipassana
means “insight” or “awareness” and its practice consists of morality, mindfulness and
experiential wisdom, achieved through self-observation of sensations without creating familiar
patterns of thought, feelings and behaviours (Adhikari et al., 2018). The Vipassana technique
normally uses silent observation of the breath as a primary focus of awareness (Burke, 2012)
and this approach has never been explored with drug users in Thailand. A series of Vipassana
techniques was tested with drug-dependent inmates in the USA. For instance, Bowen and
colleagues used a quasi-experimental design to compare an intensive ten-day VM course with
treatment-as-usual (TAU) and found that VM contributed to a significant reduction in substance
abuse (alcohol, marijuana and crack cocaine), decrease in psychiatric symptoms and
enhanced positive psychological outcomes (locus of control and optimism) at three-month
follow-up (Bowen et al., 2006) . In 2007, these researchers employed VM with an incarcerated
population at a minimum-security jail in Seattle and found that VM participants reported a
decrease in attempts to avoid unwanted thoughts related to alcohol use (Bowen et al., 2007).
Similarly, in a study conducted at North Rehabilitation Facility there were no significant
differences in severity of post-traumatic stress disorder (PTSD) symptoms between Vipassana
and TAU groups but Vipassana intervention predicted lower alcohol consumption at
three-month follow-up (Simpson et al., 2007). Those drug users who had poorer outcomes
from treatments than their peers often had psychological disorders (PTSD, anxiety, stress)
co-occurring with substance abuse (Swendsen and Merikangas, 2000) but there is little
evidence of studies assessing empathy in drug users. Empathy is referred to as cognitive and
affective aspects that are strongly associated with helping behaviours, and sociability that leads
to non-aggressive responses to conflicts (Asada et al., 2004). This might be a valuable skill set
for recovering drug users. Several forms of empathy have been described, including trait and
state empathies. Trait empathy refers to showing empathetic concern for those in need, while
state or situational empathy involves displaying empathy under specific circumstances
(Batson et al., 1987). An individual who has low trait empathy is likely to experience more
social problems in daily life, which in turn leads to maladaptive use of substances as a
problem-solving approach (Thoma et al., 2013). Unfortunately, in Thailand there have been no
trials of Vipassana for inmates or in rehabilitation centres, and few reports mention comorbidity
of psychological issues and substance abuse.
This study was a pilot study to assess effectiveness of Vipassana approach in reducing drug use
and psychological disorders in drug-dependent women at a rehabilitation centre.
Methods
Mixed methods with a randomised controlled trial and focus group interviews were employed.
A randomised controlled trial was carried out in a female rehabilitation ward at a treatment and
rehabilitation centre in Pathum Thani province, Central region, Thailand. This centre has a
drug-free environment in which individual residents are prohibited from consuming any illegal
drugs. Nurses in the rehabilitation ward distributed information about the study and collected
informed consent from participants. Participation was voluntary. Residents were eligible if they
were aged 18 years or over, had illegal substance problems, and were proficient in spoken and
written Thai. Participants showing severe psychotic symptoms and those who disrupted others
while meditating were excluded from the study. Potential participants were assured that
information related to drug use would be not disclosed or shared with staff in the centre.
Participants were selected through a simple random allocation by a nurse, and were matched on
demographic characteristics (age, education, and marital status) to undertake VM or be in a
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control group (TAU). A battery of self-report questionnaires was employed at one week prior to
and one month after the intervention.
There were 24 participants randomly allocated to the Vipassana course and 22 received TAU.
Subsequently, 10 participants withdrew from each group, leaving 14 in the intervention and 12 in
the control group at one-month follow-up. Ethics approval was given by the Institutional Review
Board of Princess Mother National Institute on Drug Abuse Treatment.
Vipassana meditation intervention
The Vipassana intervention was delivered by a monk who had more than 20 years’ experience of
teaching children and adults. There were three components of the Vipassana exercise, a 1-h
sitting meditation, a 1-h walking meditation and 15min for discussion and answering questions,
with a 15-min break between the first two meditations. It was delivered each day for five
consecutive days. This Vipassana course was based upon empirical studies that showed how an
intensive mindfulness course with brief mindfulness sessions for 20–25min on four to five
consecutive days enhanced attentional and working memory performance (Tang et al., 2007;
Zeidan et al., 2010). In Goenka and Hart’s Vipassana programme carried out in prisons, the first
three days were allocated to a foundation of raising awareness of the breath and observing the
impermanence of individuals’ thoughts (Goenka and Hart, 2000), a concept already perceived by
Thais from their religious practice. Western societies are considered as “talking” cultures (Pagis,
2015) and when persons from these cultures are asked to practice complete silence, they require
substantial time to achieve the desired outcomes. In contrast, Thai people require a short time
period to attain complete silence. Therefore, the duration of Vipassana practice in this study was
2.5 h a day for five consecutive days, and this was considered adequate for practising silent
observation and thought awareness. Engaging in social interaction with others should not affect
results in a Thai study.
The intervention began with a sitting meditation in which all participants were instructed to sit on
the floor, with legs crossed, backs straight and eyes closed. They were to focus on awareness of
their breathing and the present moment. Participants were directed simply to notice their
thoughts and feelings without judging and when their thoughts wandered, to draw attention back
gently to their breathing. In the walking mediation, participants were asked to walk at a slow pace,
to direct attention to their feet instead of their breathing and be aware of each foot rising and
falling. Before the end of each day’s session, participants were encouraged to ask questions
about meditation experiences and the benefits of meditation in helping to manage craving and
other symptoms. After finished the morning meditation, participants were required to attend their
mandatory normal daily activities in the centre.
Instruments
Participants completed four self-administered instruments, Beck Depression Inventory (BDI),
Interpersonal Reactivity Index (IRI), Mindfulness Attention Awareness Scale (MAAS) and Daily
Drug-Taking Questionnaire one week before and one month after the intervention.
Demographic information was collected, including age, sex, marital status and education, and
details of drug use including number of previous admissions and duration of substance use.
BDI is a 21-item self-report scale that measures cognitive distortions underlying depressive
symptoms. The scale is widely used in clinical and non-clinical samples (Beck et al., 1996). It is
scored on a four-point scale from “0” to “3” with higher scores indicating increasing symptom
severity. Cognitive/affective and somatic symptoms are summed separately, with items 11 and
15–21 representing somatic symptoms (e.g. irritability, work difficulty, insomnia). Internal
consistency (Cronbach’s α) of the sample was 0.878.
IRI is a 28-item scale measuring four empathetic components, empathic concern (EC), personal
distress (PD), Perspective Taking (PT) and Fantasy (F). Each subdomain has seven items (Davis,
1980, 1983) with each item describing a particular characteristic of empathy. Items are rated on a
five-point scale, ranging from “0¼ Does not describe me well” to “4¼Describes me well”.
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Items are summed, with a total score of 0 to 28 for each subscale. Higher scores in each subscale
represent higher functioning in that aspect of empathy. Cronbach’s α was 0.661.
MAAS is a 15-item single dimension assessing trait mindfulness regarding frequency of openness
and awareness of ongoing events and experience (Brown and Ryan, 2003). Trait mindfulness
refers to an individual’s ability to achieve mindfulness without meditative experiences and can be
stable over time, while state mindfulness is the condition that can be attained through specific
meditation practice (Quickel et al., 2014). The instrument is scored on a six-point Likert scale
ranging from “almost always” to “almost never”. Higher total scores purportedly reflect higher
mindfulness experiences. Cronbach’s α for the instrument was 0.753.
Daily Drug-Taking Questionnaire measures use of 14 illegal substances (e.g. tobacco, marijuana,
cocaine, methamphetamine, ecstasy, heroin) in the past 30 days (Parks, 2001).
Qualitative: focus group interviews
The group of 12 intervention participants voluntarily participated in an informal focus group
interview inside the centre to explore their life histories of using illegal substances, perceptions of
engaging in substance abuse, the impact of Vipassana programme on drug addiction and ideas
about how to improve the programme.
Data analysis
Descriptive statistics for demographic and illicit drug use variables were presented as
percentages, means and standard deviations (SD). χ2 test was employed to analyse
categorical data and t-test was used to determine mean difference between two groups.
Scores on the depression, empathy and mindfulness scales were compared both
pre- and post-intervention and across groups by t-test. p-values below 0.05 were taken as
statistically significant.
Content analysis for focus group interviews
Two research assistants read and re-read transcripts to retrieve axial codes and inter-coder
agreement was checked. Discrepancies between coders were resolved by the principal
investigator, leading to a consensus-coded transcript used in the final analysis. The codes were
used to identify themes and specific categories emerging from the text.
Results
Female participants were aged from 18 to 45 years old, with a mean age of 29.54 years for each
group. Most women had finished primary school, nearly 45 per cent of control group participants
were married while 60 per cent of the intervention group were single.
For most women, this was their first admission to the centre (72.73 per cent for control vs
79.17 per cent for intervention). Nearly 55 per cent of the control group had used illegal drugs for
six to ten years while nearly 42 per cent of the intervention group years had used illegal drugs for
over ten years. Across both groups, the most widely used substance was a combination of
methamphetamine and ice. There were no significant differences (p W0.05) between groups on
demographic or drug use data, see Table I.
Results of pre- and post-intervention psychological assessments are shown in Table II.
There were no significant differences on the IRI between groups or before and after the
intervention for total scores or any of the empathy domains, fantasy, EC, PT and PD. The total
empathy score was higher in the intervention than the control group after completing the
intervention (60.21 ± 9.09 vs 58.25 ± 9.48, t(24)¼ –0.53, p ¼ 0.59). Similarly, on the BDI there
were no significant differences for cognitive and somatic categories between pre- and
post-test. When comparing the groups at one-month post-intervention, the intervention group
showed a larger fall in total depression scores (mean difference¼ 3.55) than the control
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group (mean difference¼ 2.18) but the difference was not statistically significant. Scores on the
MAAS were lower in the intervention group than the control group at 1-month post-intervention
(64.04 ± 14.20 vs 62.62 ± 18.44) but the difference was not significant. Surprisingly,
members of both groups had completely stopped using illegal substances at 1-month
follow-up (data not shown).
Table II Comparison psychological assessments between groups and pre-post intervention
Pre-assessment 1-month post intervention
Control
(Mean±SD)
Intervention
(Mean±SD) t-test p-value
Control
(Mean±SD)
Intervention
(Mean±SD) t-test p-value
Empathy (interpersonal reactivity index)
Fantasy 12.13±4.61 11.83±3.18 0.25 0.79 11.50±4.98 12.35±2.76 −0.53 0.60
Empathic concern 20.72±3.11 20.25±4.27 0.43 0.66 21.00±3.56 19.92±4.59 0.66 0.51
Perspective taking 15.63±3.10 13.95±3.01 1.85 0.07 14.66±4.03 14.92±4.25 −0.16 0.87
Personal Distress 13.13±3.65 12.62±5.26 0.38 0.70 11.08±3.62 13.00±4.22 −1.24 0.22
Total empathy 61.63±8.62 58.66±7.66 1.23 0.22 58.25±9.48 60.21±9.09 −0.53 0.59
Depression (beck depression inventory)
Cognitive 11.27±4.96 11.54±6.17 −0.16 0.87 10.00±5.55 9.71±6.63 0.11 0.90
Somatic 3.90±3.30 5.08±3.61 −1.15 0.25 3.00±3.07 3.35±3.43 −0.28 0.78
Total depression 15.18±7.35 16.62±9.24 −0.58 0.56 13.00±7.62 13.07±9.44 −0.02 0.98
Total mindfulness 62.31±7.65 64.04±14.20 −0.51 0.60 64.25±13.81 62.62±18.44 0.25 0.80
Table I Demographic and substance abuse variables between groups
Demographic Control Intervention t-test p-value
Age (years)
(Mean±SD) 29.54±6.56 29.54±7.43 0.00 0.99
χ2 test
Marital status
Single 6 (37.50%) 14 (58.33%) 1.89 0.38
Married 7 (43.75%) 6 (25 %)
Widowed, separated, divorced 3 (18.75%) 4 (16.67%)
Education
Primary school 9 (60%) 13 (56.52%) 2.05 0.35
Secondary school 2 (13.33%) 7 (30.43%)
Diploma, certificate or degree 4 (26.67%) 3 (13.04%)
Number of previous admission
One 16 (72.73%) 19 (79.17%) 0.26 0.73
W 1 6 (27.27%) 5 (20.83%)
Duration of substance use (years)
o5 6 (27.27%) 9 (37.50%) 5.97 0.50
6–10 12 (54.55%) 5 (20.83%)
W10 4 (18.18%) 10 (41.67%)
Mean±SD 8.07+4.31 10.00+7.69
Type of substance use
Methamphetamine 6 (27.27%) 6 (25%)
Mean+SD (tabs) 7.37±9.53 6.50± 5.31 1.73 0.78
Ice 4 (18.18%) 3 (12.50%)
Mean+SD (grams) 1.22±0.63 0.88± 0.54
Marijuana 0 2 (8.33%)
Methamphetamine + Cigarette 2 (9.09%) 5 (20.83%)
Methamphetamine + Ice 10 (45.45%) 8 (33.33%)
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Qualitative results
Onset of drug dependence and types of substances used
Drug users had started taking illegal substance at a very young age and all of them had been
using for more than ten years:
“9”, “10”, “11 years old”,
“11”, “15”, “more than 20 years”.
Various illegal substances were used, including ice and methamphetamines, sometimes in
conjunction with cigarettes, and intakes ranged from a few tablets to large amounts:
I used a combined drug once, sometimes lots but some occasions were a few.
Original cause of drug addictions
Several reasons for drug dependence were mentioned, but family issues were the main
precipitating cause of drug addiction:
I used drugs due to working. If I was not working, there was no need to consume drugs.
I ran away from home because of family problems. During that time, I lived with cousins who traded
illegal substances. Anyone who sold drugs, was most likely to consume as well. I helped them to trade
drugs that was a starting point of using drugs.
I started using “ice” at 12 years old because of parents’ divorce.
I began taking drugs because I saw my friends could stay up a whole night for playing cards, so I used
that drug to stay up late at night.
Temporarily stopping substance use
Although they were addicted to substances, they had been able to stop using sometimes without
developing withdrawal symptoms:
“I have taken drugs for 14 years but I stopped using them sometimes”, “I had no symptoms of
withdrawal but felt sleepy and did not want to eat anything”.
When I did not use drugs, no any symptoms were present. It seemed when consumed drugs, I felt
thrilling, energetic and ready to work.
I did not have any withdrawal symptom. I thought I did not become a drug addict – it seemed like a
habit, taking a drug to get something done.
Reasons for being unable to stop use
Familiar environments and socialisation with friends were the main reasons that drug dependent
persons could not quit:
I thought people abused drugs because of habits. When I have money, I can’t resist purchasing drugs.
It seemed inevitable. I attempted so many times to quit but seemed impossible. I thought I was in a
familiar environment that encouraged me to do that.
I could temporarily quit using drugs some days but when friends turned up, I could avoid socialising
with them.
Benefits of mindfulness practice
When users participated in mindfulness practice, they learned how to control desires to consume
drugs and developed an awareness of right and wrong. Although they had never taken drugs
while residing in the centre, nor did they display withdrawal symptoms, they wanted options to
resist engaging in drugs:
While undertaking a mindfulness course, a master told us that we should be aware of our thoughts
whether we are inclined to the drugs. Maintaining meditative exercise could help us to ease feelings of
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craving and when we do it repeatedly, it will cease craving eventually because the ability to quit drugs is
upon our mind. We need to practice and get succeed by ourselves.
When reminded about the drugs, we have to be aware of our thoughts and maintain contemplation of
such idea.
When I meditated, I reduced a desire and intention to consume drugs.
Drug users learned to restrain their feelings, distinguish correct behaviour from wrongful acts and
became willing to do good deeds for their family in future:
I learn how to control my emotions and decrease my turmoil feeling after practicing mindfulness.
When I meditated, it was quiet and previous images and thoughts from the past passed through my
mind, thereby giving me understanding of matters in the past. It seemed it reminded me of what I had
done wrong previously.
After practicing mediation, I changed my attitude and don’t want to repeat itself as in the past. The
drugs destroyed my family. I want to be a goodmum for my kids and a good daughter for my mum […]
I thought our mind is more powerful than craving. If we intend to quit drugs, so we can do it.
Adverse effects of mindfulness training
Women indicated they developed muscle soreness after sitting with crossed legs for 1 h without
moving during Vipassana practice:
The first day of practicing I was very sore, I hardly moved my legs. However, when went through a
second day, I felt very good, relaxing and being calm.
Discussion
This study showed that VM seemed to have no beneficial effects on psychological measures
including depression, empathy or mindfulness for drug users at a rehabilitation centre in Thailand.
These findings are not consistent with previous studies in the Western world. However, women
using the Thai Vipassana approach appeared to show slightly decreased depression scores on
both cognitive and somatic subdomains, but differences were not statistically significant. There
are several possible reasons for these findings. First, the length of time of spent practicing
Vipassana in this study was shorter than that used in similar studies in the USA. For instance, in
one study of an incarcerated population the standardised Vipassana course ran for ten days and
required 11 h of meditation exercises every day (Hart, 1987; Marlatt, 2002). Subjects were
housed separately from other inmates throughout the course. In contrast, in the Thai study
reported here, women undertook 2.5 h of meditation for five consecutive days and lived with their
peers. Even so, they showed positive results for enhanced self-awareness and self-control to
overcome the desire to engage in drugs and were able to distinguish right from wrong through
Vipassana mediation, as reported in qualitative results. Carmody and Baer (2008) carried out an
eight-week mindfulness programme for nearly 200 subjects and found that a longer practice time
was strongly associated with an increase in mindfulness and wellbeing and reduction in emotional
disorders. Increasing the length of meditation practice enabled meditators not to react to
immediate unpleasant thoughts and to maintain an inner stability, which in turn resulted in
growing self-awareness and self-control (Carmody and Baer, 2008). Frequency of mindfulness
practice helped participants to maintain a mindful stance, which was the goal of the exercise
(Soler et al., 2014).
Second, people with previous experience of meditation practices may show different results to
novices. This argument was supported by Soler and colleagues, who indicated that people with
prior mindfulness experiences had higher scores on mindfulness domains than naïve meditators
(Soler et al., 2014). Both control and intervention participants in this study had used Vipassana
approach from a very young age when accompanying their parents to temples for traditional
Buddhist practices, and this approach has also been taught to primary school students at public
schools in Thailand (Chansomsak and Vale, 2008). Hence it was unsurprising that no difference in
mindfulness score was found between groups or between pre- and post-intervention.
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Third, the early age of onset of drug use and use of other drugs in addition to methamphetamine
may be associated with no significant changes in psychological disorders. A US study clearly
demonstrated that use of methamphetamine with other drugs was strongly associated with an
increase of abuse (sexual and physical), lifetime suicidal thoughts, psychotic and psychosis
disorders (Christian et al., 2007), and this may have reduced the effectiveness of the intervention.
Although the quantitative results showed no benefits from the Vipassana exercise on psychological
variables the focus group interviews captured positive aspects of this technique, including increasing
self-awareness, self-control, being calm and learning right from wrongful conduct. The quantitative
self-report assessments may have been unable to detect and differentiate psychological symptoms
between meditators and non-meditators. Consistently, Leigh and colleagues found mindfulness
scores to be higher in a substance abuse group than a comparison group (Leigh et al., 2005) and
MacKillop and Anderson pointed out there were no significant differences onMAAS scores between
participants with and without previous meditation experience (MacKillop et al., 2007). Additionally,
ethnicity may play a significant role in detection of psychological disorders using self-administered
instruments even where those assessments reflected high internal reliability and validity in the
samples, because cultural and social norms influence an understanding and interpretation of the
wording of psychosomatic properties.
Limitations of the study
Selection bias played an important part in the study because recruitment was organised by staff
members from the institute. There were an insufficient number of participants to meet effect size
criteria, limiting the ability to generalise results to similar populations. There was a lack of gender
diversity in the study, with all participants being female. According to staff of the institute, it was
not possible to separate participants from other inmates after finishing the intervention each day,
as reported by Hart (1987) and Marlatt (2002), because they were required to follow their usual
treatment and rehabilitation programs and this may have interfered with research outcomes.
Policy implications
As discussed above, the quantitative research findings from the study showed that use of the
Vipassana approach was unlikely to lead to success. However, the qualitative evidence
demonstrated that the Vipassana approach still provided benefits for drug users by enhancing
self-awareness, self-control and improving moral values. This approach is culturally appropriate
and consistent with Thai Buddhism and it should be integrated into routine treatment and
rehabilitation programs in the organisation to synergise achievements of outcomes. Frequent
Vipassana exercises should be considered for meditation courses in future rather an intensive
activity of 10 or 11 h a day which is not a feasible daily routine for the general population or drug
dependent persons. The beneficial effects of reducing psychological disorders and improving
self-awareness could develop when practising Vipassana regularly.
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